nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—NDUFS2—Doxorubicin—testicular cancer	0.204	0.31	CbGbCtD
Metformin—NDUFS3—Doxorubicin—testicular cancer	0.204	0.31	CbGbCtD
Metformin—NDUFS7—Doxorubicin—testicular cancer	0.204	0.31	CbGbCtD
Metformin—SLC22A2—Vinblastine—testicular cancer	0.0245	0.0372	CbGbCtD
Metformin—SLC22A2—Cisplatin—testicular cancer	0.0225	0.0341	CbGbCtD
Metformin—NDUFA2—Podofilox—Etoposide—testicular cancer	0.00258	0.539	CbGdCrCtD
Metformin—NDUFA2—Vincristine—Vinblastine—testicular cancer	0.00221	0.461	CbGdCrCtD
Metformin—ND6—embryo—testicular cancer	0.00169	0.00878	CbGeAlD
Metformin—NDUFAF3—gonad—testicular cancer	0.00168	0.00871	CbGeAlD
Metformin—NDUFA5—embryo—testicular cancer	0.00164	0.00851	CbGeAlD
Metformin—NDUFC1—seminal vesicle—testicular cancer	0.00163	0.00846	CbGeAlD
Metformin—NDUFS1—embryo—testicular cancer	0.00162	0.00839	CbGeAlD
Metformin—NDUFAF1—seminal vesicle—testicular cancer	0.0016	0.00832	CbGeAlD
Metformin—NDUFAF2—seminal vesicle—testicular cancer	0.00158	0.00818	CbGeAlD
Metformin—NDUFB3—seminal vesicle—testicular cancer	0.00158	0.00818	CbGeAlD
Metformin—PRKAB1—Regulation of AMPK activity via LKB1—STK11—testicular cancer	0.00155	0.063	CbGpPWpGaD
Metformin—NDUFB4—embryo—testicular cancer	0.00153	0.00794	CbGeAlD
Metformin—NDUFAF4—seminal vesicle—testicular cancer	0.00153	0.00794	CbGeAlD
Metformin—NDUFB6—seminal vesicle—testicular cancer	0.00153	0.00794	CbGeAlD
Metformin—NDUFB9—embryo—testicular cancer	0.00151	0.00784	CbGeAlD
Metformin—NDUFB10—seminal vesicle—testicular cancer	0.00151	0.00782	CbGeAlD
Metformin—NDUFA13—gonad—testicular cancer	0.0015	0.0078	CbGeAlD
Metformin—NDUFA9—gonad—testicular cancer	0.0015	0.0078	CbGeAlD
Metformin—NDUFA4—embryo—testicular cancer	0.0015	0.0078	CbGeAlD
Metformin—NDUFA12—seminal vesicle—testicular cancer	0.0015	0.00777	CbGeAlD
Metformin—NDUFB7—seminal vesicle—testicular cancer	0.0015	0.00777	CbGeAlD
Metformin—NDUFB11—embryo—testicular cancer	0.00149	0.00775	CbGeAlD
Metformin—NDUFB1—seminal vesicle—testicular cancer	0.00149	0.00771	CbGeAlD
Metformin—NDUFS8—seminal vesicle—testicular cancer	0.00149	0.00771	CbGeAlD
Metformin—SLC29A4—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00148	0.0602	CbGpPWpGaD
Metformin—NDUFB5—seminal vesicle—testicular cancer	0.00147	0.00761	CbGeAlD
Metformin—NDUFA6—seminal vesicle—testicular cancer	0.00147	0.00761	CbGeAlD
Metformin—NDUFS4—seminal vesicle—testicular cancer	0.00146	0.00756	CbGeAlD
Metformin—NDUFB4—seminal vesicle—testicular cancer	0.00144	0.00746	CbGeAlD
Metformin—NDUFV2—gonad—testicular cancer	0.00144	0.00746	CbGeAlD
Metformin—NDUFAB1—seminal vesicle—testicular cancer	0.00143	0.00741	CbGeAlD
Metformin—NDUFA8—seminal vesicle—testicular cancer	0.00142	0.00737	CbGeAlD
Metformin—NDUFB9—seminal vesicle—testicular cancer	0.00142	0.00737	CbGeAlD
Metformin—NDUFA4—seminal vesicle—testicular cancer	0.00141	0.00732	CbGeAlD
Metformin—NDUFB11—seminal vesicle—testicular cancer	0.0014	0.00728	CbGeAlD
Metformin—NDUFV1—seminal vesicle—testicular cancer	0.0014	0.00728	CbGeAlD
Metformin—NDUFS5—seminal vesicle—testicular cancer	0.00139	0.00724	CbGeAlD
Metformin—NDUFB8—seminal vesicle—testicular cancer	0.00139	0.00724	CbGeAlD
Metformin—PRKAB1—Energy dependent regulation of mTOR by LKB1-AMPK—STK11—testicular cancer	0.00133	0.0539	CbGpPWpGaD
Metformin—ND3—gonad—testicular cancer	0.00131	0.00682	CbGeAlD
Metformin—ND5—gonad—testicular cancer	0.00131	0.00682	CbGeAlD
Metformin—ND2—gonad—testicular cancer	0.00131	0.00682	CbGeAlD
Metformin—ND4L—gonad—testicular cancer	0.00131	0.00682	CbGeAlD
Metformin—NDUFA7—testis—testicular cancer	0.0013	0.00672	CbGeAlD
Metformin—ND4—gonad—testicular cancer	0.00127	0.0066	CbGeAlD
Metformin—SLC29A4—testis—testicular cancer	0.00124	0.00641	CbGeAlD
Metformin—NDUFA9—female gonad—testicular cancer	0.00122	0.00634	CbGeAlD
Metformin—NDUFAF3—testis—testicular cancer	0.00121	0.00628	CbGeAlD
Metformin—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00121	0.049	CbGpPWpGaD
Metformin—NDUFA1—female gonad—testicular cancer	0.0012	0.00624	CbGeAlD
Metformin—PRKAB1—seminal vesicle—testicular cancer	0.00119	0.0062	CbGeAlD
Metformin—NDUFA10—gonad—testicular cancer	0.00119	0.00617	CbGeAlD
Metformin—NDUFB2—gonad—testicular cancer	0.00117	0.00606	CbGeAlD
Metformin—NDUFV2—female gonad—testicular cancer	0.00117	0.00606	CbGeAlD
Metformin—ND6—gonad—testicular cancer	0.00115	0.00596	CbGeAlD
Metformin—NDUFB3—gonad—testicular cancer	0.00114	0.00591	CbGeAlD
Metformin—NDUFC2—seminal vesicle—testicular cancer	0.00113	0.00584	CbGeAlD
Metformin—NDUFA5—gonad—testicular cancer	0.00111	0.00578	CbGeAlD
Metformin—NDUFS1—gonad—testicular cancer	0.0011	0.00569	CbGeAlD
Metformin—NDUFB10—gonad—testicular cancer	0.00109	0.00565	CbGeAlD
Metformin—NDUFA13—testis—testicular cancer	0.00108	0.00562	CbGeAlD
Metformin—NDUFA9—testis—testicular cancer	0.00108	0.00562	CbGeAlD
Metformin—NDUFS2—seminal vesicle—testicular cancer	0.00108	0.00562	CbGeAlD
Metformin—NDUFB7—gonad—testicular cancer	0.00108	0.00561	CbGeAlD
Metformin—NDUFS3—seminal vesicle—testicular cancer	0.00107	0.00555	CbGeAlD
Metformin—ND3—female gonad—testicular cancer	0.00107	0.00554	CbGeAlD
Metformin—ND2—female gonad—testicular cancer	0.00107	0.00554	CbGeAlD
Metformin—ND5—female gonad—testicular cancer	0.00107	0.00554	CbGeAlD
Metformin—ND4L—female gonad—testicular cancer	0.00107	0.00554	CbGeAlD
Metformin—NDUFB5—gonad—testicular cancer	0.00106	0.0055	CbGeAlD
Metformin—NDUFA6—gonad—testicular cancer	0.00106	0.0055	CbGeAlD
Metformin—NDUFB4—gonad—testicular cancer	0.00104	0.00539	CbGeAlD
Metformin—NDUFV2—testis—testicular cancer	0.00104	0.00538	CbGeAlD
Metformin—ND4—female gonad—testicular cancer	0.00103	0.00536	CbGeAlD
Metformin—NDUFAB1—gonad—testicular cancer	0.00103	0.00536	CbGeAlD
Metformin—NDUFB9—gonad—testicular cancer	0.00103	0.00532	CbGeAlD
Metformin—NDUFA8—gonad—testicular cancer	0.00103	0.00532	CbGeAlD
Metformin—NDUFV1—gonad—testicular cancer	0.00101	0.00526	CbGeAlD
Metformin—NDUFA2—female gonad—testicular cancer	0.00101	0.00525	CbGeAlD
Metformin—NDUFB8—gonad—testicular cancer	0.00101	0.00523	CbGeAlD
Metformin—NDUFS5—gonad—testicular cancer	0.00101	0.00523	CbGeAlD
Metformin—NDUFA4L2—testis—testicular cancer	0.00101	0.00523	CbGeAlD
Metformin—NDUFA10—female gonad—testicular cancer	0.000966	0.00501	CbGeAlD
Metformin—NDUFC1—female gonad—testicular cancer	0.000957	0.00497	CbGeAlD
Metformin—NDUFB2—female gonad—testicular cancer	0.000949	0.00493	CbGeAlD
Metformin—ND4L—testis—testicular cancer	0.000947	0.00492	CbGeAlD
Metformin—ND5—testis—testicular cancer	0.000947	0.00492	CbGeAlD
Metformin—ND3—testis—testicular cancer	0.000947	0.00492	CbGeAlD
Metformin—ND2—testis—testicular cancer	0.000947	0.00492	CbGeAlD
Metformin—NDUFAF1—female gonad—testicular cancer	0.000941	0.00489	CbGeAlD
Metformin—NDUFA7—lymph node—testicular cancer	0.000939	0.00487	CbGeAlD
Metformin—ND6—female gonad—testicular cancer	0.000933	0.00484	CbGeAlD
Metformin—NDUFB3—female gonad—testicular cancer	0.000926	0.00481	CbGeAlD
Metformin—NDUFAF2—female gonad—testicular cancer	0.000926	0.00481	CbGeAlD
Metformin—PRKAB1—mTOR signalling—STK11—testicular cancer	0.000917	0.0372	CbGpPWpGaD
Metformin—ND4—testis—testicular cancer	0.000916	0.00476	CbGeAlD
Metformin—NDUFA5—female gonad—testicular cancer	0.000904	0.0047	CbGeAlD
Metformin—NDUFA11—female gonad—testicular cancer	0.000904	0.0047	CbGeAlD
Metformin—NDUFA2—testis—testicular cancer	0.000898	0.00466	CbGeAlD
Metformin—NDUFB6—female gonad—testicular cancer	0.000898	0.00466	CbGeAlD
Metformin—NDUFAF4—female gonad—testicular cancer	0.000898	0.00466	CbGeAlD
Metformin—NDUFS1—female gonad—testicular cancer	0.000891	0.00463	CbGeAlD
Metformin—PRKAB1—PKB-mediated events—STK11—testicular cancer	0.00089	0.0362	CbGpPWpGaD
Metformin—NDUFB10—female gonad—testicular cancer	0.000885	0.00459	CbGeAlD
Metformin—NDUFB7—female gonad—testicular cancer	0.000878	0.00456	CbGeAlD
Metformin—NDUFA12—female gonad—testicular cancer	0.000878	0.00456	CbGeAlD
Metformin—NDUFS8—female gonad—testicular cancer	0.000872	0.00453	CbGeAlD
Metformin—NDUFB1—female gonad—testicular cancer	0.000872	0.00453	CbGeAlD
Metformin—PRKAB1—gonad—testicular cancer	0.000863	0.00448	CbGeAlD
Metformin—NDUFA6—female gonad—testicular cancer	0.000861	0.00447	CbGeAlD
Metformin—NDUFB5—female gonad—testicular cancer	0.000861	0.00447	CbGeAlD
Metformin—NDUFA10—testis—testicular cancer	0.000856	0.00445	CbGeAlD
Metformin—NDUFS4—female gonad—testicular cancer	0.000855	0.00444	CbGeAlD
Metformin—NDUFC1—testis—testicular cancer	0.000849	0.00441	CbGeAlD
Metformin—NDUFB4—female gonad—testicular cancer	0.000844	0.00438	CbGeAlD
Metformin—NDUFB2—testis—testicular cancer	0.000842	0.00437	CbGeAlD
Metformin—NDUFAB1—female gonad—testicular cancer	0.000839	0.00435	CbGeAlD
Metformin—NDUFAF1—testis—testicular cancer	0.000835	0.00433	CbGeAlD
Metformin—NDUFA8—female gonad—testicular cancer	0.000833	0.00433	CbGeAlD
Metformin—NDUFB9—female gonad—testicular cancer	0.000833	0.00433	CbGeAlD
Metformin—NDUFA4—female gonad—testicular cancer	0.000828	0.0043	CbGeAlD
Metformin—ND6—testis—testicular cancer	0.000828	0.0043	CbGeAlD
Metformin—NDUFB11—female gonad—testicular cancer	0.000823	0.00427	CbGeAlD
Metformin—NDUFV1—female gonad—testicular cancer	0.000823	0.00427	CbGeAlD
Metformin—NDUFAF2—testis—testicular cancer	0.000821	0.00426	CbGeAlD
Metformin—NDUFB3—testis—testicular cancer	0.000821	0.00426	CbGeAlD
Metformin—NDUFS5—female gonad—testicular cancer	0.000819	0.00425	CbGeAlD
Metformin—NDUFB8—female gonad—testicular cancer	0.000819	0.00425	CbGeAlD
Metformin—NDUFC2—gonad—testicular cancer	0.000814	0.00422	CbGeAlD
Metformin—NDUFA11—testis—testicular cancer	0.000802	0.00416	CbGeAlD
Metformin—NDUFA5—testis—testicular cancer	0.000802	0.00416	CbGeAlD
Metformin—NDUFAF4—testis—testicular cancer	0.000796	0.00413	CbGeAlD
Metformin—NDUFB6—testis—testicular cancer	0.000796	0.00413	CbGeAlD
Metformin—NDUFS1—testis—testicular cancer	0.00079	0.0041	CbGeAlD
Metformin—NDUFB10—testis—testicular cancer	0.000785	0.00407	CbGeAlD
Metformin—NDUFS2—gonad—testicular cancer	0.000782	0.00406	CbGeAlD
Metformin—NDUFA12—testis—testicular cancer	0.000779	0.00404	CbGeAlD
Metformin—NDUFB7—testis—testicular cancer	0.000779	0.00404	CbGeAlD
Metformin—NDUFB1—testis—testicular cancer	0.000774	0.00402	CbGeAlD
Metformin—NDUFS8—testis—testicular cancer	0.000774	0.00402	CbGeAlD
Metformin—NDUFS3—gonad—testicular cancer	0.000773	0.00401	CbGeAlD
Metformin—NDUFS7—female gonad—testicular cancer	0.000767	0.00398	CbGeAlD
Metformin—NDUFA6—testis—testicular cancer	0.000763	0.00396	CbGeAlD
Metformin—NDUFB5—testis—testicular cancer	0.000763	0.00396	CbGeAlD
Metformin—NDUFS4—testis—testicular cancer	0.000758	0.00394	CbGeAlD
Metformin—SLC29A4—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000753	0.0306	CbGpPWpGaD
Metformin—NDUFV2—lymph node—testicular cancer	0.00075	0.0039	CbGeAlD
Metformin—NDUFB4—testis—testicular cancer	0.000749	0.00389	CbGeAlD
Metformin—NDUFAB1—testis—testicular cancer	0.000744	0.00386	CbGeAlD
Metformin—NDUFA8—testis—testicular cancer	0.000739	0.00384	CbGeAlD
Metformin—NDUFB9—testis—testicular cancer	0.000739	0.00384	CbGeAlD
Metformin—NDUFA4—testis—testicular cancer	0.000735	0.00381	CbGeAlD
Metformin—NDUFV1—testis—testicular cancer	0.00073	0.00379	CbGeAlD
Metformin—NDUFB11—testis—testicular cancer	0.00073	0.00379	CbGeAlD
Metformin—NDUFA4L2—lymph node—testicular cancer	0.00073	0.00379	CbGeAlD
Metformin—NDUFS5—testis—testicular cancer	0.000726	0.00377	CbGeAlD
Metformin—NDUFB8—testis—testicular cancer	0.000726	0.00377	CbGeAlD
Metformin—PRKAB1—female gonad—testicular cancer	0.000702	0.00364	CbGeAlD
Metformin—ND5—lymph node—testicular cancer	0.000686	0.00356	CbGeAlD
Metformin—ND3—lymph node—testicular cancer	0.000686	0.00356	CbGeAlD
Metformin—ND2—lymph node—testicular cancer	0.000686	0.00356	CbGeAlD
Metformin—ND4L—lymph node—testicular cancer	0.000686	0.00356	CbGeAlD
Metformin—NDUFS7—testis—testicular cancer	0.00068	0.00353	CbGeAlD
Metformin—ND4—lymph node—testicular cancer	0.000664	0.00345	CbGeAlD
Metformin—NDUFC2—female gonad—testicular cancer	0.000661	0.00343	CbGeAlD
Metformin—NDUFA2—lymph node—testicular cancer	0.000651	0.00338	CbGeAlD
Metformin—ND1—gonad—testicular cancer	0.000642	0.00333	CbGeAlD
Metformin—NDUFS2—female gonad—testicular cancer	0.000636	0.0033	CbGeAlD
Metformin—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000631	0.0256	CbGpPWpGaD
Metformin—NDUFS3—female gonad—testicular cancer	0.000628	0.00326	CbGeAlD
Metformin—PRKAB1—testis—testicular cancer	0.000622	0.00323	CbGeAlD
Metformin—NDUFA10—lymph node—testicular cancer	0.000621	0.00322	CbGeAlD
Metformin—NDUFC1—lymph node—testicular cancer	0.000615	0.00319	CbGeAlD
Metformin—NDUFB2—lymph node—testicular cancer	0.00061	0.00317	CbGeAlD
Metformin—NDUFAF1—lymph node—testicular cancer	0.000605	0.00314	CbGeAlD
Metformin—SLC47A1—seminal vesicle—testicular cancer	0.000603	0.00313	CbGeAlD
Metformin—ND6—lymph node—testicular cancer	0.0006	0.00311	CbGeAlD
Metformin—NDUFB3—lymph node—testicular cancer	0.000595	0.00309	CbGeAlD
Metformin—NDUFAF2—lymph node—testicular cancer	0.000595	0.00309	CbGeAlD
Metformin—NDUFC2—testis—testicular cancer	0.000586	0.00304	CbGeAlD
Metformin—NDUFA5—lymph node—testicular cancer	0.000581	0.00302	CbGeAlD
Metformin—NDUFA11—lymph node—testicular cancer	0.000581	0.00302	CbGeAlD
Metformin—NDUFAF4—lymph node—testicular cancer	0.000577	0.003	CbGeAlD
Metformin—NDUFB6—lymph node—testicular cancer	0.000577	0.003	CbGeAlD
Metformin—NDUFS1—lymph node—testicular cancer	0.000573	0.00297	CbGeAlD
Metformin—NDUFB10—lymph node—testicular cancer	0.000569	0.00295	CbGeAlD
Metformin—NDUFB7—lymph node—testicular cancer	0.000565	0.00293	CbGeAlD
Metformin—NDUFA12—lymph node—testicular cancer	0.000565	0.00293	CbGeAlD
Metformin—NDUFS2—testis—testicular cancer	0.000564	0.00293	CbGeAlD
Metformin—NDUFB1—lymph node—testicular cancer	0.000561	0.00291	CbGeAlD
Metformin—NDUFS8—lymph node—testicular cancer	0.000561	0.00291	CbGeAlD
Metformin—NDUFS3—testis—testicular cancer	0.000557	0.00289	CbGeAlD
Metformin—NDUFA6—lymph node—testicular cancer	0.000553	0.00287	CbGeAlD
Metformin—NDUFB5—lymph node—testicular cancer	0.000553	0.00287	CbGeAlD
Metformin—NDUFS4—lymph node—testicular cancer	0.00055	0.00285	CbGeAlD
Metformin—SLC47A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000548	0.0223	CbGpPWpGaD
Metformin—NDUFB4—lymph node—testicular cancer	0.000543	0.00282	CbGeAlD
Metformin—NDUFAB1—lymph node—testicular cancer	0.000539	0.0028	CbGeAlD
Metformin—NDUFA8—lymph node—testicular cancer	0.000536	0.00278	CbGeAlD
Metformin—NDUFB9—lymph node—testicular cancer	0.000536	0.00278	CbGeAlD
Metformin—NDUFA4—lymph node—testicular cancer	0.000533	0.00276	CbGeAlD
Metformin—NDUFB11—lymph node—testicular cancer	0.000529	0.00275	CbGeAlD
Metformin—NDUFV1—lymph node—testicular cancer	0.000529	0.00275	CbGeAlD
Metformin—NDUFS5—lymph node—testicular cancer	0.000526	0.00273	CbGeAlD
Metformin—NDUFB8—lymph node—testicular cancer	0.000526	0.00273	CbGeAlD
Metformin—ND1—female gonad—testicular cancer	0.000521	0.00271	CbGeAlD
Metformin—SLC22A3—embryo—testicular cancer	0.000512	0.00266	CbGeAlD
Metformin—NDUFS7—lymph node—testicular cancer	0.000493	0.00256	CbGeAlD
Metformin—SLC22A3—seminal vesicle—testicular cancer	0.000481	0.0025	CbGeAlD
Metformin—ND1—testis—testicular cancer	0.000462	0.0024	CbGeAlD
Metformin—PRKAB1—lymph node—testicular cancer	0.000451	0.00234	CbGeAlD
Metformin—PRKAB1—PI3K Cascade—STK11—testicular cancer	0.000438	0.0178	CbGpPWpGaD
Metformin—SLC47A1—gonad—testicular cancer	0.000436	0.00226	CbGeAlD
Metformin—PRKAB1—AMPK Signaling—STK11—testicular cancer	0.000433	0.0176	CbGpPWpGaD
Metformin—NDUFC2—lymph node—testicular cancer	0.000425	0.00221	CbGeAlD
Metformin—NDUFS2—lymph node—testicular cancer	0.000409	0.00212	CbGeAlD
Metformin—NDUFS3—lymph node—testicular cancer	0.000404	0.0021	CbGeAlD
Metformin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000396	0.0161	CbGpPWpGaD
Metformin—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000369	0.015	CbGpPWpGaD
Metformin—PRKAB1—IRS-mediated signalling—STK11—testicular cancer	0.000366	0.0149	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events—STK11—testicular cancer	0.000356	0.0145	CbGpPWpGaD
Metformin—SLC47A1—female gonad—testicular cancer	0.000354	0.00184	CbGeAlD
Metformin—PRKAB1—IRS-related events triggered by IGF1R—STK11—testicular cancer	0.000353	0.0143	CbGpPWpGaD
Metformin—SLC22A3—gonad—testicular cancer	0.000348	0.0018	CbGeAlD
Metformin—PRKAB1—Insulin receptor signalling cascade—STK11—testicular cancer	0.000344	0.014	CbGpPWpGaD
Metformin—PRKAB1—IGF1R signaling cascade—STK11—testicular cancer	0.000344	0.014	CbGpPWpGaD
Metformin—ND1—lymph node—testicular cancer	0.000335	0.00174	CbGeAlD
Metformin—SLC47A1—testis—testicular cancer	0.000314	0.00163	CbGeAlD
Metformin—PRKAB1—PI3K Cascade—FGFR3—testicular cancer	0.000301	0.0122	CbGpPWpGaD
Metformin—SLC22A3—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000287	0.0116	CbGpPWpGaD
Metformin—PRKAB1—Signaling by Insulin receptor—STK11—testicular cancer	0.000286	0.0116	CbGpPWpGaD
Metformin—SLC22A3—female gonad—testicular cancer	0.000282	0.00147	CbGeAlD
Metformin—SLC47A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000279	0.0113	CbGpPWpGaD
Metformin—PRKAB1—IRS-mediated signalling—FGFR3—testicular cancer	0.000252	0.0102	CbGpPWpGaD
Metformin—SLC22A3—testis—testicular cancer	0.000251	0.0013	CbGeAlD
Metformin—PRKAB1—IRS-related events—FGFR3—testicular cancer	0.000245	0.00995	CbGpPWpGaD
Metformin—PRKAB1—IRS-related events triggered by IGF1R—FGFR3—testicular cancer	0.000243	0.00986	CbGpPWpGaD
Metformin—PRKAB1—Insulin receptor signalling cascade—FGFR3—testicular cancer	0.000236	0.0096	CbGpPWpGaD
Metformin—PRKAB1—IGF1R signaling cascade—FGFR3—testicular cancer	0.000236	0.0096	CbGpPWpGaD
Metformin—SLC47A1—lymph node—testicular cancer	0.000228	0.00118	CbGeAlD
Metformin—PRKAB1—Signaling by Insulin receptor—FGFR3—testicular cancer	0.000196	0.00798	CbGpPWpGaD
Metformin—Asthenia—Dactinomycin—testicular cancer	0.000192	0.00163	CcSEcCtD
Metformin—Influenza—Epirubicin—testicular cancer	0.000191	0.00162	CcSEcCtD
Metformin—Neutropenia—Methotrexate—testicular cancer	0.000191	0.00162	CcSEcCtD
Metformin—Dehydration—Doxorubicin—testicular cancer	0.00019	0.00161	CcSEcCtD
Metformin—Paraesthesia—Cisplatin—testicular cancer	0.00019	0.00161	CcSEcCtD
Metformin—Thrombocytopenia—Etoposide—testicular cancer	0.00019	0.00161	CcSEcCtD
Metformin—Upper respiratory tract infection—Methotrexate—testicular cancer	0.00019	0.00161	CcSEcCtD
Metformin—Liver function test abnormal—Doxorubicin—testicular cancer	0.000189	0.0016	CcSEcCtD
Metformin—Dyspnoea—Cisplatin—testicular cancer	0.000189	0.0016	CcSEcCtD
Metformin—Skin disorder—Etoposide—testicular cancer	0.000188	0.00159	CcSEcCtD
Metformin—Hyperhidrosis—Etoposide—testicular cancer	0.000187	0.00159	CcSEcCtD
Metformin—Pancreatitis—Epirubicin—testicular cancer	0.000187	0.00159	CcSEcCtD
Metformin—Abdominal pain upper—Doxorubicin—testicular cancer	0.000187	0.00158	CcSEcCtD
Metformin—Angina pectoris—Epirubicin—testicular cancer	0.000186	0.00158	CcSEcCtD
Metformin—Breast disorder—Doxorubicin—testicular cancer	0.000185	0.00156	CcSEcCtD
Metformin—Anorexia—Etoposide—testicular cancer	0.000185	0.00156	CcSEcCtD
Metformin—Decreased appetite—Cisplatin—testicular cancer	0.000184	0.00156	CcSEcCtD
Metformin—Diarrhoea—Dactinomycin—testicular cancer	0.000183	0.00155	CcSEcCtD
Metformin—Nasopharyngitis—Doxorubicin—testicular cancer	0.000183	0.00155	CcSEcCtD
Metformin—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000183	0.00155	CcSEcCtD
Metformin—Vomiting—Bleomycin—testicular cancer	0.000183	0.00155	CcSEcCtD
Metformin—Infestation NOS—Methotrexate—testicular cancer	0.000182	0.00154	CcSEcCtD
Metformin—Drowsiness—Methotrexate—testicular cancer	0.000182	0.00154	CcSEcCtD
Metformin—Infestation—Methotrexate—testicular cancer	0.000182	0.00154	CcSEcCtD
Metformin—SLC22A3—lymph node—testicular cancer	0.000182	0.000943	CbGeAlD
Metformin—Hypotension—Etoposide—testicular cancer	0.000181	0.00153	CcSEcCtD
Metformin—Rash—Bleomycin—testicular cancer	0.000181	0.00153	CcSEcCtD
Metformin—Dermatitis—Bleomycin—testicular cancer	0.000181	0.00153	CcSEcCtD
Metformin—SLC22A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00018	0.0073	CbGpPWpGaD
Metformin—Neutropenia—Epirubicin—testicular cancer	0.000179	0.00151	CcSEcCtD
Metformin—Abdominal distension—Doxorubicin—testicular cancer	0.000178	0.00151	CcSEcCtD
Metformin—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000178	0.0015	CcSEcCtD
Metformin—Influenza—Doxorubicin—testicular cancer	0.000177	0.0015	CcSEcCtD
Metformin—Asthenia—Ifosfamide—testicular cancer	0.000176	0.00149	CcSEcCtD
Metformin—Feeling abnormal—Cisplatin—testicular cancer	0.000174	0.00148	CcSEcCtD
Metformin—Paraesthesia—Etoposide—testicular cancer	0.000174	0.00147	CcSEcCtD
Metformin—Pruritus—Ifosfamide—testicular cancer	0.000174	0.00147	CcSEcCtD
Metformin—Pancreatitis—Doxorubicin—testicular cancer	0.000173	0.00147	CcSEcCtD
Metformin—Dyspnoea—Etoposide—testicular cancer	0.000173	0.00146	CcSEcCtD
Metformin—Somnolence—Etoposide—testicular cancer	0.000172	0.00146	CcSEcCtD
Metformin—Angina pectoris—Doxorubicin—testicular cancer	0.000172	0.00146	CcSEcCtD
Metformin—Hepatobiliary disease—Methotrexate—testicular cancer	0.000172	0.00146	CcSEcCtD
Metformin—Nausea—Bleomycin—testicular cancer	0.000171	0.00144	CcSEcCtD
Metformin—Infestation—Epirubicin—testicular cancer	0.00017	0.00144	CcSEcCtD
Metformin—Infestation NOS—Epirubicin—testicular cancer	0.00017	0.00144	CcSEcCtD
Metformin—Drowsiness—Epirubicin—testicular cancer	0.00017	0.00144	CcSEcCtD
Metformin—Vomiting—Dactinomycin—testicular cancer	0.00017	0.00144	CcSEcCtD
Metformin—Rash—Dactinomycin—testicular cancer	0.000169	0.00143	CcSEcCtD
Metformin—Decreased appetite—Etoposide—testicular cancer	0.000169	0.00143	CcSEcCtD
Metformin—Diarrhoea—Ifosfamide—testicular cancer	0.000168	0.00142	CcSEcCtD
Metformin—SLC22A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000168	0.0068	CbGpPWpGaD
Metformin—Gastrointestinal disorder—Etoposide—testicular cancer	0.000167	0.00142	CcSEcCtD
Metformin—Fatigue—Etoposide—testicular cancer	0.000167	0.00141	CcSEcCtD
Metformin—Neuropathy peripheral—Epirubicin—testicular cancer	0.000167	0.00141	CcSEcCtD
Metformin—Constipation—Etoposide—testicular cancer	0.000166	0.0014	CcSEcCtD
Metformin—Neutropenia—Doxorubicin—testicular cancer	0.000165	0.0014	CcSEcCtD
Metformin—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000164	0.00139	CcSEcCtD
Metformin—Hepatitis—Methotrexate—testicular cancer	0.000163	0.00138	CcSEcCtD
Metformin—Dizziness—Ifosfamide—testicular cancer	0.000162	0.00137	CcSEcCtD
Metformin—Hepatobiliary disease—Epirubicin—testicular cancer	0.000161	0.00136	CcSEcCtD
Metformin—Feeling abnormal—Etoposide—testicular cancer	0.00016	0.00135	CcSEcCtD
Metformin—Nausea—Dactinomycin—testicular cancer	0.000159	0.00135	CcSEcCtD
Metformin—Gastrointestinal pain—Etoposide—testicular cancer	0.000159	0.00134	CcSEcCtD
Metformin—Infestation NOS—Doxorubicin—testicular cancer	0.000158	0.00133	CcSEcCtD
Metformin—Infestation—Doxorubicin—testicular cancer	0.000158	0.00133	CcSEcCtD
Metformin—Drowsiness—Doxorubicin—testicular cancer	0.000158	0.00133	CcSEcCtD
Metformin—Vomiting—Ifosfamide—testicular cancer	0.000156	0.00132	CcSEcCtD
Metformin—Bradycardia—Epirubicin—testicular cancer	0.000156	0.00132	CcSEcCtD
Metformin—Rash—Ifosfamide—testicular cancer	0.000155	0.00131	CcSEcCtD
Metformin—Dermatitis—Ifosfamide—testicular cancer	0.000155	0.00131	CcSEcCtD
Metformin—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000155	0.00131	CcSEcCtD
Metformin—Urticaria—Etoposide—testicular cancer	0.000154	0.0013	CcSEcCtD
Metformin—Rhinitis—Epirubicin—testicular cancer	0.000153	0.0013	CcSEcCtD
Metformin—Abdominal pain—Etoposide—testicular cancer	0.000153	0.0013	CcSEcCtD
Metformin—Hepatitis—Epirubicin—testicular cancer	0.000153	0.00129	CcSEcCtD
Metformin—Eye disorder—Methotrexate—testicular cancer	0.000153	0.00129	CcSEcCtD
Metformin—Hypoaesthesia—Epirubicin—testicular cancer	0.000152	0.00129	CcSEcCtD
Metformin—Asthenia—Cisplatin—testicular cancer	0.000152	0.00128	CcSEcCtD
Metformin—Cardiac disorder—Methotrexate—testicular cancer	0.000152	0.00128	CcSEcCtD
Metformin—Oedema peripheral—Epirubicin—testicular cancer	0.000151	0.00128	CcSEcCtD
Metformin—Connective tissue disorder—Epirubicin—testicular cancer	0.00015	0.00127	CcSEcCtD
Metformin—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000149	0.00126	CcSEcCtD
Metformin—Angiopathy—Methotrexate—testicular cancer	0.000148	0.00125	CcSEcCtD
Metformin—Immune system disorder—Methotrexate—testicular cancer	0.000148	0.00125	CcSEcCtD
Metformin—Mediastinal disorder—Methotrexate—testicular cancer	0.000147	0.00125	CcSEcCtD
Metformin—Chills—Methotrexate—testicular cancer	0.000147	0.00124	CcSEcCtD
Metformin—Nausea—Ifosfamide—testicular cancer	0.000146	0.00123	CcSEcCtD
Metformin—SLC22A3—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000146	0.00592	CbGpPWpGaD
Metformin—Diarrhoea—Cisplatin—testicular cancer	0.000145	0.00123	CcSEcCtD
Metformin—Bradycardia—Doxorubicin—testicular cancer	0.000144	0.00122	CcSEcCtD
Metformin—Eye disorder—Epirubicin—testicular cancer	0.000143	0.00121	CcSEcCtD
Metformin—Erythema—Methotrexate—testicular cancer	0.000142	0.0012	CcSEcCtD
Metformin—Malnutrition—Methotrexate—testicular cancer	0.000142	0.0012	CcSEcCtD
Metformin—Flushing—Epirubicin—testicular cancer	0.000142	0.0012	CcSEcCtD
Metformin—Cardiac disorder—Epirubicin—testicular cancer	0.000142	0.0012	CcSEcCtD
Metformin—Rhinitis—Doxorubicin—testicular cancer	0.000142	0.0012	CcSEcCtD
Metformin—Hepatitis—Doxorubicin—testicular cancer	0.000142	0.0012	CcSEcCtD
Metformin—Hypoaesthesia—Doxorubicin—testicular cancer	0.000141	0.00119	CcSEcCtD
Metformin—Oedema peripheral—Doxorubicin—testicular cancer	0.000139	0.00118	CcSEcCtD
Metformin—Dysgeusia—Methotrexate—testicular cancer	0.000139	0.00118	CcSEcCtD
Metformin—Asthenia—Etoposide—testicular cancer	0.000139	0.00118	CcSEcCtD
Metformin—Connective tissue disorder—Doxorubicin—testicular cancer	0.000139	0.00118	CcSEcCtD
Metformin—Angiopathy—Epirubicin—testicular cancer	0.000139	0.00117	CcSEcCtD
Metformin—Immune system disorder—Epirubicin—testicular cancer	0.000138	0.00117	CcSEcCtD
Metformin—Mediastinal disorder—Epirubicin—testicular cancer	0.000138	0.00117	CcSEcCtD
Metformin—PRKAB1—Direct p53 effectors—MMP2—testicular cancer	0.000137	0.00558	CbGpPWpGaD
Metformin—Chills—Epirubicin—testicular cancer	0.000137	0.00116	CcSEcCtD
Metformin—Pruritus—Etoposide—testicular cancer	0.000137	0.00116	CcSEcCtD
Metformin—Vomiting—Cisplatin—testicular cancer	0.000135	0.00114	CcSEcCtD
Metformin—Vision blurred—Methotrexate—testicular cancer	0.000134	0.00113	CcSEcCtD
Metformin—Rash—Cisplatin—testicular cancer	0.000133	0.00113	CcSEcCtD
Metformin—Dermatitis—Cisplatin—testicular cancer	0.000133	0.00113	CcSEcCtD
Metformin—Erythema—Epirubicin—testicular cancer	0.000133	0.00113	CcSEcCtD
Metformin—Malnutrition—Epirubicin—testicular cancer	0.000133	0.00113	CcSEcCtD
Metformin—Diarrhoea—Etoposide—testicular cancer	0.000133	0.00112	CcSEcCtD
Metformin—Eye disorder—Doxorubicin—testicular cancer	0.000132	0.00112	CcSEcCtD
Metformin—Ill-defined disorder—Methotrexate—testicular cancer	0.000132	0.00112	CcSEcCtD
Metformin—Cardiac disorder—Doxorubicin—testicular cancer	0.000131	0.00111	CcSEcCtD
Metformin—Flushing—Doxorubicin—testicular cancer	0.000131	0.00111	CcSEcCtD
Metformin—Flatulence—Epirubicin—testicular cancer	0.000131	0.00111	CcSEcCtD
Metformin—Dysgeusia—Epirubicin—testicular cancer	0.00013	0.0011	CcSEcCtD
Metformin—Angiopathy—Doxorubicin—testicular cancer	0.000128	0.00109	CcSEcCtD
Metformin—Malaise—Methotrexate—testicular cancer	0.000128	0.00109	CcSEcCtD
Metformin—Dizziness—Etoposide—testicular cancer	0.000128	0.00108	CcSEcCtD
Metformin—Muscle spasms—Epirubicin—testicular cancer	0.000128	0.00108	CcSEcCtD
Metformin—NDUFB11—Metabolism—HPGDS—testicular cancer	0.000128	0.0052	CbGpPWpGaD
Metformin—Immune system disorder—Doxorubicin—testicular cancer	0.000128	0.00108	CcSEcCtD
Metformin—Mediastinal disorder—Doxorubicin—testicular cancer	0.000128	0.00108	CcSEcCtD
Metformin—Chills—Doxorubicin—testicular cancer	0.000127	0.00107	CcSEcCtD
Metformin—Nausea—Cisplatin—testicular cancer	0.000126	0.00106	CcSEcCtD
Metformin—Vision blurred—Epirubicin—testicular cancer	0.000126	0.00106	CcSEcCtD
Metformin—Ill-defined disorder—Epirubicin—testicular cancer	0.000124	0.00105	CcSEcCtD
Metformin—Vomiting—Etoposide—testicular cancer	0.000123	0.00104	CcSEcCtD
Metformin—Malnutrition—Doxorubicin—testicular cancer	0.000123	0.00104	CcSEcCtD
Metformin—Erythema—Doxorubicin—testicular cancer	0.000123	0.00104	CcSEcCtD
Metformin—Rash—Etoposide—testicular cancer	0.000122	0.00103	CcSEcCtD
Metformin—Dermatitis—Etoposide—testicular cancer	0.000122	0.00103	CcSEcCtD
Metformin—Headache—Etoposide—testicular cancer	0.000121	0.00103	CcSEcCtD
Metformin—Flatulence—Doxorubicin—testicular cancer	0.000121	0.00103	CcSEcCtD
Metformin—Myalgia—Methotrexate—testicular cancer	0.000121	0.00103	CcSEcCtD
Metformin—Chest pain—Methotrexate—testicular cancer	0.000121	0.00103	CcSEcCtD
Metformin—Dysgeusia—Doxorubicin—testicular cancer	0.000121	0.00102	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00012	0.00102	CcSEcCtD
Metformin—Malaise—Epirubicin—testicular cancer	0.00012	0.00102	CcSEcCtD
Metformin—Discomfort—Methotrexate—testicular cancer	0.00012	0.00101	CcSEcCtD
Metformin—Syncope—Epirubicin—testicular cancer	0.000119	0.00101	CcSEcCtD
Metformin—Muscle spasms—Doxorubicin—testicular cancer	0.000118	0.001	CcSEcCtD
Metformin—Palpitations—Epirubicin—testicular cancer	0.000118	0.000996	CcSEcCtD
Metformin—NDUFB3—Metabolism—HPGDS—testicular cancer	0.000117	0.00475	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—HPGDS—testicular cancer	0.000117	0.00475	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—HPGDS—testicular cancer	0.000117	0.00475	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—HPGDS—testicular cancer	0.000117	0.00475	CbGpPWpGaD
Metformin—Loss of consciousness—Epirubicin—testicular cancer	0.000117	0.00099	CcSEcCtD
Metformin—Vision blurred—Doxorubicin—testicular cancer	0.000116	0.000983	CcSEcCtD
Metformin—Infection—Methotrexate—testicular cancer	0.000115	0.000976	CcSEcCtD
Metformin—Nausea—Etoposide—testicular cancer	0.000115	0.000974	CcSEcCtD
Metformin—Hypertension—Epirubicin—testicular cancer	0.000115	0.000973	CcSEcCtD
Metformin—Ill-defined disorder—Doxorubicin—testicular cancer	0.000114	0.000967	CcSEcCtD
Metformin—Nervous system disorder—Methotrexate—testicular cancer	0.000114	0.000964	CcSEcCtD
Metformin—Thrombocytopenia—Methotrexate—testicular cancer	0.000114	0.000962	CcSEcCtD
Metformin—Chest pain—Epirubicin—testicular cancer	0.000113	0.000959	CcSEcCtD
Metformin—Myalgia—Epirubicin—testicular cancer	0.000113	0.000959	CcSEcCtD
Metformin—Skin disorder—Methotrexate—testicular cancer	0.000113	0.000954	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000113	0.000953	CcSEcCtD
Metformin—Hyperhidrosis—Methotrexate—testicular cancer	0.000112	0.00095	CcSEcCtD
Metformin—Discomfort—Epirubicin—testicular cancer	0.000112	0.000948	CcSEcCtD
Metformin—Malaise—Doxorubicin—testicular cancer	0.000111	0.00094	CcSEcCtD
Metformin—Anorexia—Methotrexate—testicular cancer	0.000111	0.000937	CcSEcCtD
Metformin—Syncope—Doxorubicin—testicular cancer	0.000111	0.000935	CcSEcCtD
Metformin—Palpitations—Doxorubicin—testicular cancer	0.000109	0.000921	CcSEcCtD
Metformin—NDUFA13—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—ND2—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—ND4L—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—ND3—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—ND5—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—ND6—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—ND4—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—HPGDS—testicular cancer	0.000109	0.00442	CbGpPWpGaD
Metformin—Oedema—Epirubicin—testicular cancer	0.000109	0.00092	CcSEcCtD
Metformin—Hypotension—Methotrexate—testicular cancer	0.000109	0.000918	CcSEcCtD
Metformin—Loss of consciousness—Doxorubicin—testicular cancer	0.000108	0.000916	CcSEcCtD
Metformin—Infection—Epirubicin—testicular cancer	0.000108	0.000914	CcSEcCtD
Metformin—Shock—Epirubicin—testicular cancer	0.000107	0.000905	CcSEcCtD
Metformin—Nervous system disorder—Epirubicin—testicular cancer	0.000107	0.000902	CcSEcCtD
Metformin—Thrombocytopenia—Epirubicin—testicular cancer	0.000106	0.0009	CcSEcCtD
Metformin—Hypertension—Doxorubicin—testicular cancer	0.000106	0.0009	CcSEcCtD
Metformin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000106	0.000895	CcSEcCtD
Metformin—Skin disorder—Epirubicin—testicular cancer	0.000106	0.000893	CcSEcCtD
Metformin—Hyperhidrosis—Epirubicin—testicular cancer	0.000105	0.000889	CcSEcCtD
Metformin—Myalgia—Doxorubicin—testicular cancer	0.000105	0.000888	CcSEcCtD
Metformin—Chest pain—Doxorubicin—testicular cancer	0.000105	0.000888	CcSEcCtD
Metformin—Paraesthesia—Methotrexate—testicular cancer	0.000104	0.000882	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000104	0.000881	CcSEcCtD
Metformin—Discomfort—Doxorubicin—testicular cancer	0.000104	0.000877	CcSEcCtD
Metformin—Anorexia—Epirubicin—testicular cancer	0.000104	0.000877	CcSEcCtD
Metformin—Dyspnoea—Methotrexate—testicular cancer	0.000104	0.000876	CcSEcCtD
Metformin—Somnolence—Methotrexate—testicular cancer	0.000103	0.000874	CcSEcCtD
Metformin—Dyspepsia—Methotrexate—testicular cancer	0.000102	0.000865	CcSEcCtD
Metformin—Hypotension—Epirubicin—testicular cancer	0.000102	0.000859	CcSEcCtD
Metformin—Decreased appetite—Methotrexate—testicular cancer	0.000101	0.000854	CcSEcCtD
Metformin—Oedema—Doxorubicin—testicular cancer	0.000101	0.000851	CcSEcCtD
Metformin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.0001	0.000848	CcSEcCtD
Metformin—Fatigue—Methotrexate—testicular cancer	0.0001	0.000847	CcSEcCtD
Metformin—Infection—Doxorubicin—testicular cancer	9.99e-05	0.000845	CcSEcCtD
Metformin—Musculoskeletal discomfort—Epirubicin—testicular cancer	9.9e-05	0.000838	CcSEcCtD
Metformin—Shock—Doxorubicin—testicular cancer	9.89e-05	0.000837	CcSEcCtD
Metformin—Nervous system disorder—Doxorubicin—testicular cancer	9.86e-05	0.000834	CcSEcCtD
Metformin—Thrombocytopenia—Doxorubicin—testicular cancer	9.85e-05	0.000833	CcSEcCtD
Metformin—Skin disorder—Doxorubicin—testicular cancer	9.77e-05	0.000826	CcSEcCtD
Metformin—Paraesthesia—Epirubicin—testicular cancer	9.76e-05	0.000826	CcSEcCtD
Metformin—Hyperhidrosis—Doxorubicin—testicular cancer	9.72e-05	0.000823	CcSEcCtD
Metformin—NDUFV3—Metabolism—HPGDS—testicular cancer	9.7e-05	0.00394	CbGpPWpGaD
Metformin—Dyspnoea—Epirubicin—testicular cancer	9.69e-05	0.00082	CcSEcCtD
Metformin—Somnolence—Epirubicin—testicular cancer	9.66e-05	0.000818	CcSEcCtD
Metformin—Anorexia—Doxorubicin—testicular cancer	9.59e-05	0.000811	CcSEcCtD
Metformin—Feeling abnormal—Methotrexate—testicular cancer	9.57e-05	0.00081	CcSEcCtD
Metformin—Dyspepsia—Epirubicin—testicular cancer	9.57e-05	0.000809	CcSEcCtD
Metformin—Gastrointestinal pain—Methotrexate—testicular cancer	9.5e-05	0.000804	CcSEcCtD
Metformin—Decreased appetite—Epirubicin—testicular cancer	9.45e-05	0.000799	CcSEcCtD
Metformin—Hypotension—Doxorubicin—testicular cancer	9.4e-05	0.000795	CcSEcCtD
Metformin—Gastrointestinal disorder—Epirubicin—testicular cancer	9.38e-05	0.000794	CcSEcCtD
Metformin—Fatigue—Epirubicin—testicular cancer	9.37e-05	0.000793	CcSEcCtD
Metformin—PRKAB1—Signaling Pathways—INSL3—testicular cancer	9.36e-05	0.0038	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—STK11—testicular cancer	9.3e-05	0.00378	CbGpPWpGaD
Metformin—Constipation—Epirubicin—testicular cancer	9.3e-05	0.000786	CcSEcCtD
Metformin—Urticaria—Methotrexate—testicular cancer	9.23e-05	0.000781	CcSEcCtD
Metformin—Abdominal pain—Methotrexate—testicular cancer	9.18e-05	0.000777	CcSEcCtD
Metformin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	9.16e-05	0.000775	CcSEcCtD
Metformin—SLC22A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	9.14e-05	0.00371	CbGpPWpGaD
Metformin—Paraesthesia—Doxorubicin—testicular cancer	9.03e-05	0.000764	CcSEcCtD
Metformin—Dyspnoea—Doxorubicin—testicular cancer	8.97e-05	0.000759	CcSEcCtD
Metformin—Feeling abnormal—Epirubicin—testicular cancer	8.96e-05	0.000758	CcSEcCtD
Metformin—Somnolence—Doxorubicin—testicular cancer	8.94e-05	0.000756	CcSEcCtD
Metformin—Gastrointestinal pain—Epirubicin—testicular cancer	8.89e-05	0.000752	CcSEcCtD
Metformin—Dyspepsia—Doxorubicin—testicular cancer	8.85e-05	0.000749	CcSEcCtD
Metformin—Decreased appetite—Doxorubicin—testicular cancer	8.74e-05	0.00074	CcSEcCtD
Metformin—Gastrointestinal disorder—Doxorubicin—testicular cancer	8.68e-05	0.000735	CcSEcCtD
Metformin—Fatigue—Doxorubicin—testicular cancer	8.67e-05	0.000734	CcSEcCtD
Metformin—Urticaria—Epirubicin—testicular cancer	8.64e-05	0.000731	CcSEcCtD
Metformin—Constipation—Doxorubicin—testicular cancer	8.6e-05	0.000728	CcSEcCtD
Metformin—Abdominal pain—Epirubicin—testicular cancer	8.59e-05	0.000727	CcSEcCtD
Metformin—SLC22A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	8.51e-05	0.00346	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—STK11—testicular cancer	8.51e-05	0.00345	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—STK11—testicular cancer	8.51e-05	0.00345	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—STK11—testicular cancer	8.51e-05	0.00345	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—STK11—testicular cancer	8.51e-05	0.00345	CbGpPWpGaD
Metformin—Asthenia—Methotrexate—testicular cancer	8.33e-05	0.000705	CcSEcCtD
Metformin—Feeling abnormal—Doxorubicin—testicular cancer	8.29e-05	0.000701	CcSEcCtD
Metformin—NDUFC2—Metabolism—HPGDS—testicular cancer	8.25e-05	0.00335	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—HPGDS—testicular cancer	8.25e-05	0.00335	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—HPGDS—testicular cancer	8.25e-05	0.00335	CbGpPWpGaD
Metformin—Gastrointestinal pain—Doxorubicin—testicular cancer	8.22e-05	0.000696	CcSEcCtD
Metformin—Pruritus—Methotrexate—testicular cancer	8.22e-05	0.000695	CcSEcCtD
Metformin—Urticaria—Doxorubicin—testicular cancer	7.99e-05	0.000676	CcSEcCtD
Metformin—Abdominal pain—Doxorubicin—testicular cancer	7.95e-05	0.000673	CcSEcCtD
Metformin—Diarrhoea—Methotrexate—testicular cancer	7.95e-05	0.000672	CcSEcCtD
Metformin—NDUFA7—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—ND4—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—ND6—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—ND2—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—ND3—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—ND4L—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—ND5—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—STK11—testicular cancer	7.91e-05	0.00321	CbGpPWpGaD
Metformin—Asthenia—Epirubicin—testicular cancer	7.8e-05	0.00066	CcSEcCtD
Metformin—NDUFS2—Metabolism—HPGDS—testicular cancer	7.75e-05	0.00315	CbGpPWpGaD
Metformin—Pruritus—Epirubicin—testicular cancer	7.69e-05	0.000651	CcSEcCtD
Metformin—Dizziness—Methotrexate—testicular cancer	7.68e-05	0.00065	CcSEcCtD
Metformin—Diarrhoea—Epirubicin—testicular cancer	7.44e-05	0.000629	CcSEcCtD
Metformin—Vomiting—Methotrexate—testicular cancer	7.38e-05	0.000625	CcSEcCtD
Metformin—Rash—Methotrexate—testicular cancer	7.32e-05	0.00062	CcSEcCtD
Metformin—Dermatitis—Methotrexate—testicular cancer	7.32e-05	0.000619	CcSEcCtD
Metformin—Headache—Methotrexate—testicular cancer	7.28e-05	0.000616	CcSEcCtD
Metformin—Asthenia—Doxorubicin—testicular cancer	7.22e-05	0.00061	CcSEcCtD
Metformin—Dizziness—Epirubicin—testicular cancer	7.19e-05	0.000608	CcSEcCtD
Metformin—Pruritus—Doxorubicin—testicular cancer	7.12e-05	0.000602	CcSEcCtD
Metformin—NDUFV3—Metabolism—STK11—testicular cancer	7.05e-05	0.00286	CbGpPWpGaD
Metformin—Vomiting—Epirubicin—testicular cancer	6.91e-05	0.000585	CcSEcCtD
Metformin—Nausea—Methotrexate—testicular cancer	6.9e-05	0.000584	CcSEcCtD
Metformin—Diarrhoea—Doxorubicin—testicular cancer	6.88e-05	0.000582	CcSEcCtD
Metformin—Rash—Epirubicin—testicular cancer	6.85e-05	0.00058	CcSEcCtD
Metformin—Dermatitis—Epirubicin—testicular cancer	6.85e-05	0.000579	CcSEcCtD
Metformin—Headache—Epirubicin—testicular cancer	6.81e-05	0.000576	CcSEcCtD
Metformin—Dizziness—Doxorubicin—testicular cancer	6.65e-05	0.000563	CcSEcCtD
Metformin—Nausea—Epirubicin—testicular cancer	6.46e-05	0.000546	CcSEcCtD
Metformin—Vomiting—Doxorubicin—testicular cancer	6.39e-05	0.000541	CcSEcCtD
Metformin—Rash—Doxorubicin—testicular cancer	6.34e-05	0.000536	CcSEcCtD
Metformin—Dermatitis—Doxorubicin—testicular cancer	6.34e-05	0.000536	CcSEcCtD
Metformin—Headache—Doxorubicin—testicular cancer	6.3e-05	0.000533	CcSEcCtD
Metformin—NDUFS3—Metabolism—STK11—testicular cancer	5.99e-05	0.00243	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—STK11—testicular cancer	5.99e-05	0.00243	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—STK11—testicular cancer	5.99e-05	0.00243	CbGpPWpGaD
Metformin—Nausea—Doxorubicin—testicular cancer	5.97e-05	0.000505	CcSEcCtD
Metformin—NDUFS2—Metabolism—STK11—testicular cancer	5.63e-05	0.00229	CbGpPWpGaD
Metformin—ND1—Metabolism—HPGDS—testicular cancer	5.31e-05	0.00216	CbGpPWpGaD
Metformin—ND1—Metabolism—STK11—testicular cancer	3.86e-05	0.00157	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—H2AFZ—testicular cancer	3e-05	0.00122	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—STK11—testicular cancer	2.98e-05	0.00121	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KITLG—testicular cancer	2.76e-05	0.00112	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—HPGDS—testicular cancer	2.48e-05	0.00101	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FGFR3—testicular cancer	2.05e-05	0.000832	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KIT—testicular cancer	1.88e-05	0.000764	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—STK11—testicular cancer	1.8e-05	0.000731	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HPGDS—testicular cancer	1.55e-05	0.000631	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HPGDS—testicular cancer	1.45e-05	0.000588	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—STK11—testicular cancer	1.13e-05	0.000458	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—STK11—testicular cancer	1.05e-05	0.000427	CbGpPWpGaD
